We’ve been wrong about cholesterol

Most of us grew up with a simple story:

High cholesterol clogs arteries. LDL is “bad,” HDL is “good.” Lower the number and you lower the risk.

That story isn’t totally wrong—but it’s incomplete in ways that matter.

When people say “we’ve been wrong about cholesterol,” they usually mean one of two things:

1. We treated cholesterol like a poison, instead of a normal (and necessary) substance your body uses every day.
2. We acted like a single blood test number could explain a disease process that’s influenced by many moving parts.

Let’s slow it down and rebuild the picture.

Cholesterol isn’t an enemy. It’s a raw material.

Cholesterol is a waxy, fat-like molecule your body uses to build and repair cells and to make hormones and other important compounds. In other words: you don’t just “have cholesterol.” You rely on it.

That matters because it changes the emotional framing. If cholesterol is essential, then the real question becomes: when do cholesterol-related markers signal risk, and when are they simply reflecting normal biology?

LDL and HDL aren’t cholesterol. They’re “carriers.”

A common misconception is that LDL and HDL are types of cholesterol. A more accurate way to think about them is that they’re lipoproteins—particles that transport cholesterol and other fats through the bloodstream.

The popular labels can still be directionally useful:

• LDL is often called “bad” because higher LDL is associated with higher risk in many populations, and LDL contributes to plaque formation.
• HDL is often called “good” because HDL is involved in reverse cholesterol transport (moving cholesterol away from tissues and toward the liver).

But the labels hide nuance.

For example, Mayo Clinic points out that not all cholesterol is the same and emphasizes the difference between LDL and HDL—helpful, but still a simplified view of a complex system. The American Heart Association similarly addresses misconceptions that come from reducing everything to “good” vs “bad.”

The bigger point: LDL and HDL are part of the transport system. They’re not moral categories.

Why the standard lipid panel can mislead people

A standard lipid panel typically reports:

• Total cholesterol
• LDL-C (LDL cholesterol, an estimate of cholesterol carried by LDL particles)
• HDL-C
• Triglycerides

These numbers can be useful. They can also create false certainty.

Here are a few ways that happens:

1. “Total cholesterol” can be a distraction

Total cholesterol lumps together several components and doesn’t tell you much about the underlying pattern by itself. People can have the same total cholesterol with very different LDL/HDL/triglyceride profiles.

1. LDL-C isn’t the same as “how many LDL particles are in circulation”

LDL-C is the amount of cholesterol being carried by LDL—not necessarily the number of LDL particles (sometimes discussed as LDL-P or ApoB in other testing approaches). Two people can have the same LDL-C but different particle counts.

This is one reason some clinicians and commentators argue that “cholesterol numbers” have been overinterpreted: the standard numbers are proxies, and proxies can be blunt instruments.

1. HDL isn’t a simple shield

It’s tempting to think: “My HDL is high, so I’m protected.” But mainstream guidance increasingly warns against treating HDL as a free pass. Higher HDL is not always better, and the relationship between HDL and risk isn’t perfectly linear.

The American Heart Association explicitly addresses misconceptions about what cholesterol values do and don’t mean, including overreliance on single markers.

So what are we actually wrong about?

We weren’t wrong that cholesterol is involved in atherosclerosis.

Where we often go wrong is in assuming:

• Heart disease is mainly a cholesterol problem.
• LDL (or total cholesterol) alone explains risk.
• Lowering cholesterol numbers always tells you the whole story of what’s happening in the artery wall.

Even articles that argue strongly against the “cholesterol hypothesis” tend to agree on one foundational truth: cholesterol is essential biology, and cardiovascular risk is not reducible to one lab value.

A more grounded way to hold it is:

• Cholesterol markers can be informative.
• They’re not the full model.
• Interpretation depends on context (overall metabolic health, family history, inflammation-related factors, and more—some of which aren’t captured in a basic lipid panel).

What you can take from this without turning it into a new dogma

It’s easy to swing from one oversimplification to another:

Old oversimplification: “Cholesterol is the villain.”

New oversimplification: “Cholesterol doesn’t matter at all.”

Neither is a great place to land.

A better takeaway is humility about what a single test can tell you—and a willingness to ask better questions:

• What exactly does this number measure?
• What does it not measure?
• Am I looking at a snapshot, or a pattern over time?
• What else in my health picture could be driving risk?

If you’ve been told your cholesterol is “high” or “fine,” the most useful upgrade isn’t panic or dismissal—it’s clarity.